This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.
The Journal of clinical endocrinology and metabolism, 99(12), E2463-71
Citation
Mear, Yves; Blanchard, Marie-Pierre; Defilles, Céline; Brue, Thierry; Figarella-Branger, Dominique; Graillon, Thomas; Manavela, Marcos; Barlier, Anne; Enjalbert, Alain; Thirion, Sylvie. (2014). Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.. The Journal of clinical endocrinology and metabolism, 99(12), E2463-71. https://doi.org/10.1210/jc.2014-2753